| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.1 |